seed
Stage
1
Investors
About
Napiferyn Biotech develops novel therapies in the field of oncology, focusing on medical innovations based on synthetic peptides targeting rare cancers.
Explore Napiferyn Biotech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.